166 related articles for article (PubMed ID: 36577160)
1. Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies.
Sun F; Zhao J; Li Y; Wang H; Cao X; Cheng W; Chen J
Int Immunopharmacol; 2023 Feb; 115():109609. PubMed ID: 36577160
[TBL] [Abstract][Full Text] [Related]
2. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern.
Meng K; Tian M; Gui X; Xie M; Gao Y; Shi S; Zhao T; Xiao Y; Cai H; Ding J
Int Immunopharmacol; 2022 Jul; 108():108704. PubMed ID: 35413677
[TBL] [Abstract][Full Text] [Related]
3. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract][Full Text] [Related]
4. Serum Human Epididymis Protein 4 as a Novel Biomarker in Identifying Patients With Interstitial Lung Disease in Rheumatoid Arthritis.
Liang L; Chen J; Di C; Zhan M; Bao H; Xia C; Fan C; Liu Y
Front Med (Lausanne); 2021; 8():755268. PubMed ID: 34765622
[No Abstract] [Full Text] [Related]
5. Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
Lin T; Xu S; Wang Y; Nian X; Shan X; Jiang T; Qiu M
Clin Exp Rheumatol; 2022 Nov; 40(11):2167-2174. PubMed ID: 35349410
[TBL] [Abstract][Full Text] [Related]
6. Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease.
Nishiyama N; Masuo M; Nukui Y; Tateishi T; Kishino M; Tateishi U; Morota K; Ohbo K; Miyazaki Y
Respir Investig; 2021 Jan; 59(1):90-98. PubMed ID: 32919933
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.
Tian M; Meng K; Gao Y; Zhang J; Xie M; Tian Y; Liu X; Ma M; Cai Y; Wu H; Ding J; Chen J; Cai H
Ann Transl Med; 2022 Sep; 10(18):992. PubMed ID: 36267722
[TBL] [Abstract][Full Text] [Related]
9. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography.
Roncella C; Barsotti S; Valentini A; Cavagna L; Castellana R; Cioffi E; Tripoli A; Zanframundo G; Biglia A; Bartholmai B; De Liperi A; Mosca M; Romei C
J Thorac Imaging; 2022 Sep; 37(5):344-351. PubMed ID: 35576535
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
13. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
Kastrati K; Nakuz TS; Kulterer OC; Geßl I; Simader E; Mrak D; Bonelli M; Kiener HP; Prayer F; Prosch H; Aletaha D; Langsteger W; Traub-Weidinger T; Blüml S; Lechner-Radner H; Hacker M; Mandl P
EClinicalMedicine; 2024 Jun; 72():102598. PubMed ID: 38633577
[TBL] [Abstract][Full Text] [Related]
14. hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.
Yu L; Li J; Chen Y; Jiang J; Fang Q; Jiang J; Wang D; Liu M
Ann Clin Lab Sci; 2018 Nov; 48(6):764-769. PubMed ID: 30610047
[TBL] [Abstract][Full Text] [Related]
15. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.
Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD
Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991
[TBL] [Abstract][Full Text] [Related]
17. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pulmonary and small airways function between idiopathic inflammatory myopathies patients with and without interstitial lung disease.
Panagopoulos PK; Georgakopoulou VE; Pezoulas VC; Malagari K; Fotiadis DI; Goules AV; Vassilakopoulos T; Tzioufas AG
Clin Exp Rheumatol; 2024 Feb; 42(2):337-343. PubMed ID: 37382448
[TBL] [Abstract][Full Text] [Related]
19. Novel Assessment of Interstitial Lung Disease Using the "Computer-Aided Lung Informatics for Pathology Evaluation and Rating" (CALIPER) Software System in Idiopathic Inflammatory Myopathies.
Ungprasert P; Wilton KM; Ernste FC; Kalra S; Crowson CS; Rajagopalan S; Bartholmai BJ
Lung; 2017 Oct; 195(5):545-552. PubMed ID: 28688028
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
